Literature DB >> 24900053

Heme products post-radiofrequency ablation obscure tumor recurrence on MR but not on PET-CT.

Syed Ramisa Ehsan1, Casey E Gooden2, David M Schuster1.   

Abstract

Entities:  

Year:  2012        PMID： 24900053      PMCID： PMC4042990          DOI： 10.1007/s13139-012-0136-x

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN： 1869-3474


× No keyword cloud information.
  11 in total

Review 1.  Interpretation of CT and MRI after radiofrequency ablation of hepatic malignancies.

Authors:  Piyaporn Limanond; Peter Zimmerman; Steven S Raman; Barbara M Kadell; David S K Lu
Journal:  AJR Am J Roentgenol       Date:  2003-12       Impact factor: 3.959

2.  Early PET/CT after radiofrequency ablation in colorectal cancer liver metastases: is it useful?

Authors:  Zhao-Yu Liu; Zhi-Hui Chang; Zai-Ming Lu; Qi-Yong Guo
Journal:  Chin Med J (Engl)       Date:  2010-07       Impact factor: 2.628

Review 3.  Evaluation of liver metastases after radiofrequency ablation: utility of 18F-FDG PET and PET/CT.

Authors:  David W Barker; Ronald J Zagoria; Kathryn A Morton; Peter V Kavanagh; Perry Shen
Journal:  AJR Am J Roentgenol       Date:  2005-04       Impact factor: 3.959

Review 4.  Therapeutic response to radiofrequency ablation of neoplastic lesions: FDG PET/CT findings.

Authors:  Nilendu C Purandare; Venkatesh Rangarajan; Sneha A Shah; Anshu R Sharma; Suyash S Kulkarni; Aniruddha V Kulkarni; Sumeet G Dua
Journal:  Radiographics       Date:  2011 Jan-Feb       Impact factor: 5.333

Review 5.  Radiofrequency ablation of hepatic metastases.

Authors:  Alexander A Parikh; Steven A Curley; Bruno D Fornage; Lee M Ellis
Journal:  Semin Oncol       Date:  2002-04       Impact factor: 4.929

6.  Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up.

Authors:  Clarisse Dromain; Thierry de Baere; Dominique Elias; Viseth Kuoch; Michel Ducreux; Valerie Boige; Peter Petrow; Alain Roche; Robert Sigal
Journal:  Radiology       Date:  2002-04       Impact factor: 11.105

7.  Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation.

Authors:  S N Goldberg; G S Gazelle; C C Compton; P R Mueller; K K Tanabe
Journal:  Cancer       Date:  2000-06-01       Impact factor: 6.860

8.  FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.

Authors:  Gregory S Anderson; Frank Brinkmann; Michael C Soulen; Abass Alavi; Hongming Zhuang
Journal:  Clin Nucl Med       Date:  2003-03       Impact factor: 7.794

9.  Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis.

Authors:  Karen Kinkel; Ying Lu; Marcus Both; Robert S Warren; Ruedi F Thoeni
Journal:  Radiology       Date:  2002-09       Impact factor: 11.105

10.  [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases.

Authors:  Vincent Donckier; Jean Luc Van Laethem; Serge Goldman; Daniel Van Gansbeke; Pascale Feron; Brigitte Ickx; David Wikler; Michel Gelin
Journal:  J Surg Oncol       Date:  2003-12       Impact factor: 3.454
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.